Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Macular Pigment and Visual Performance in Glaucoma
NCT03959592Phase 2Terminated
- Start
- Aug 2019
- Primary completion
- Nov 2021
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial (2 arms). Primary endpoints: Change in Contrast Sensitivity at 6 months and Change in the Macular Pigment Optical Density at 6 months. Started Aug 2019; status: terminated.
Beyond the preview
Go deeper on NCT03959592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03959592.